Select a region and then select a language.
We research, develop, manufacture and distribute specialist immunodiagnostic assays & instrumentation.
Find a local patient group near you.
Freelite aids the detection and monitoring of Multiple Myeloma and related diseases
The Freelite assay is composed of two sensitive and specific immunodiagnostic tests to measure kappa (κ) and lambda (λ) free light chains
It is the only free light chain assay recommended by national and international guidelines
Freelite® - The standard of care to help rule out, diagnose…
Together Freelite & Hevylite provide optimal detection
International Myeloma Working Group updated criteria for the…
Myeloma patient pathway - Freelite and Hevylite
The Binding Site, Mayo Clinic collaborate to improve identification and accurate measurement of monoclonal proteins present in multiple myeloma using mass spectrometry
01 March 2017
Landmark “iStopMM” trial to start
13 April 2016
The National Institute for Health and Care Excellence (NICE) has published guidelines on the diagnosis and management of myeloma
16 March 2016
19 April 2018
03 May 2018
Join us on our social channels
Follow us on LinkedIn